myology l carnitine Synergy (D) – Mark Hyman, MD L Carnitine 3500 – Metabolic

Matrix metalloproteinase-9 activation in hyperhomocysteinemic rats is triggered by the opening of the mitochondrial permeability transition pore and antagonism of the N-methyl-D-aspartate receptor-1 (NMDA-R1), resulting in myocyte dysfunction due to elevated calcium overload and oxidative stress [40]

doi: 10.1016/S1474-4422(06)70440-9

Each serving provides 3000 mg of L-carnitine alongside green tea extract, which is commonly used to support metabolism and antioxidant activity

Combining KRAS inhibitors with glutaminolysis inhibitors may create synthetic lethality by simultaneously blocking oncogenic signaling and metabolic support